6 days ago · Cortexyme, Inc. is a clinical-stage biotechnology company focused on the development of treatments for Alzheimer’s disease and other chronic conditions associated with bacterial proteases.

Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on advancing therapeutics for rare and degenerative diseases, today reported the successful completion of its …

Dec 31, 2025 · The CRTx® is a fixed income total return index that tracks the aggregate performance generated from a dynamic basket of Credit Risk Transfer (CRT) securities that have been issued into …

Feb 18, 2022 · Cortexyme, Inc. (CRTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall …

Get the latest CRISM' Therapeutics Corp (CRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

CRTX | Complete Crism Therapeutics Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Welcome to the overview page for CRTX (CRTX), where you can find comprehensive stock information and company updates. Explore the latest news on strategic partnerships, quarterly and annual …

4 days ago · View Cortexyme (NASDAQ:CRTX) historical prices, past price performance, and an advanced CRTX stock chart at MarketBeat.

Jan 10, 2026 · What's going on at Cortexyme (NASDAQ:CRTX)? Read today's CRTX news from trusted media outlets at MarketBeat.

4 days ago · CRISM Therapeutics Corporation is clinical stage company, having developed an innovative drug delivery technology to improve the clinical performance of cancer treatments for solid …